Literature DB >> 31140170

Understanding Peroxisome Proliferator-Activated Receptors: From the Structure to the Regulatory Actions on Metabolism.

María Lamas Bervejillo1, Ana María Ferreira2.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are multi-domains proteins, belonging to the superfamily of nuclear receptors, which mainly act as ligand-activated transcription factors. A variety of lipophilic molecules, including long-chain polyunsaturated fatty acids and eicosanoids, are capable of binding to PPAR, although the nature of the physiological ligands is still under debate. PPARs regulate the expression of a set of genes involved in glucose and lipid metabolism as well as in the control of inflammatory responses. Herein we review the main molecular and cellular events associated with the activation of PPARs and their effects on metabolism.

Entities:  

Keywords:  Lipid metabolism; PPARα; PPARβ/δ; PPARγ; Peroxisome proliferator-activated receptors; Transactivation; Transrepression

Mesh:

Substances:

Year:  2019        PMID: 31140170     DOI: 10.1007/978-3-030-11488-6_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

Review 1.  Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song; Jingrong Lin
Journal:  Mol Cell Biochem       Date:  2022-03-29       Impact factor: 3.396

2.  Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.

Authors:  Timothy D O'Connell; Richard Preston Mason; Matthew J Budoff; Ann Marie Navar; Gregory C Shearer
Journal:  Eur Heart J Suppl       Date:  2020-10-06       Impact factor: 1.803

3.  Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis.

Authors:  Xue-Feng Li; Guang-Bin Jiang; Shi-Yan Cheng; Ya-Feng Song; Cai Deng; Yu-Ming Niu; Jun-Wei Cai
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

4.  Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice.

Authors:  Bahman Rostama; Megan Beauchemin; Celeste Bouchard; Elizabeth Bernier; Calvin P H Vary; Meghan May; Karen L Houseknecht
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

5.  Atorvastatin protects against postoperative neurocognitive disorder via a peroxisome proliferator-activated receptor-gamma signaling pathway in mice.

Authors:  Yinan Yang; Changwei Wei; Jinhu Liu; Danxu Ma; Chao Xiong; Dandan Lin; Anshi Wu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.